The Omnia is still very much in concept mode — a phenomenon popular in the automotive world that has since spilled over into consumer electronics. That is to say that Withings’ splashiest product of CES 2025 may never be a product. Among other things, a body-scanning smart mirror would likely be cost prohibitive for consumers. […]
Withings’ Omnia is a full-size body-scanning health mirror Read More »
Cristian Ponce was wearing an Indiana Jones costume when he met his co-founder Théo Schäfer. It was at a Halloween party in 2023 thrown by Entrepreneur First, a startup program that introduces founders to one another before they launch an idea. The two hit it off, Ponce remembers. Schäfer had studied at MIT with a
In case you hadn’t noticed, there are a lot of mental health startups out there these days, many of which were prompted to launch following the pandemic and the subsequent widespread focus on mental health. However, they often have scant relationships with clinical trials or healthcare systems. A new venture from the U.K.’s KHP Ventures,
A new $25M fund aims to give UK mental health startups a shot in the arm Read More »
Aqemia, a French startup that’s meshing “quantum-inspired physics” with machine learning to find new drugs, has raised $38 million in a fresh round of funding led by San Francisco-based VC firm Cathay Innovation. This is Aqemia’s second fundraise of the year — it announced a €30 million ($31.5 million) raise back in January — and
Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI Read More »
A U.S. breast-screening program claims to demonstrate the potential benefits of using artificial intelligence (AI) in mammography screening, with women who paid for AI-enhanced scans 21% more likely to have cancer detected. DeepHealth, an AI firm owned by radiology giant RadNet, presented its findings at the annual meeting of the Radiological Society of North America
Study claims AI could boost detection of breast cancer by 21% Read More »
Back in the heady days of 2021, Heartcore Capital planned to focus on consumer technology with a $200 million fund. Fast-forward to 2024, and its latest fund will now ‘leaven the bread’ of that thesis, with a fresh $180 million (€170M) to go broader and more generalist than that earlier thesis. Some 17-years into the
Although heart disease is the leading cause of death in the United States, a significant portion of people who experience heart attacks are unaware that they have the underlying condition. Cleerly, a cardiovascular imaging startup, hopes to fix this. By analyzing CT scans of the heart, the company’s AI software aims to identify early stage
Cleerly raises $106M from Insight Partners for AI heart health early detection Read More »
Cancer incidence is on the rise, particularly among younger adults, but most new drug compounds fail to progress through clinical trials. According to French entrepreneur Fanny Jaulin (on the right in the picture above), the problem lies with clinical trial design. “Just because a drug isn’t successful in clinical trials doesn’t mean it’s not a
Orakl Oncology combines data and biology to bring new drugs to cancer patients Read More »
Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly are seeing big uptake and new investment. Cradle is one of these, focused on protein design — and it just raised $73 million to build out its labs and team. Cradle appeared in 2022 as part
Cradle builds out its protein-design AI platform (and wet lab) with $73M in new funding Read More »
Writing the documentation that must go alongside the development of new drugs is a highly labor-intensive process: not much software is used and there’s a shortage of expert writers. Paris-based Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing. It’s now raised €6 million
Biolevate’s raises €6M to helps medical writers keep up with the pace of new drugs Read More »
